Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer

		IMAGE: Ritsuko Komaki, M.D., is a professor and program director of Lung Cancer Research and Thoracic Radiation Oncology in the Department of Radiation Oncology at M. D. Anderson. Click here for more information.

CHICAGO - Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results, opening the door to larger scale investigation, according to new research from The University of Texas M. D. Anderson Cancer Center.